glp 1 news today More GLP-1 news: in a late-stage study in type 2 diabetes and elevated cardiovascular risk, our new GLP-1 pill showed cardiovascular safety. Read more: https://e.lilly/4myJlm8 GLP-1 Pipeline Update: November 2025
Description
R., Melton, L
[PubMed Central ID: PMC4926453]
The development of reliable biomarkers is also critical for monitoring therapeutic response and advancing clinical translation
Expanding options for patients Widening the pool of available options beyond injectables could help meet consumer demand more effectively
Simply complete our free online health assessment to get started
